In recent years, thanks to imaging tests, the number of diagnoses in early stages has increased.
Kidney cancer usually does not produce symptoms until more advanced stages. For this reason, more than half of the cases are diagnosed incidentally in diagnostic tests performed for another reason.
More than half of kidney tumors are diagnosed incidentally in the course of diagnostic tests performed for another reason, when the tumor has not yet caused any symptoms. If this has not occurred, but there is suspicion of kidney cancer, a series of diagnostic tests will be carried out:
The imaging tests described above provide essential information on the size of the tumor, its extent, its potential invasion of local veins such as the inferior vena cava, the status of lymph nodes or neighboring organs. This is important in determining further treatment.
With the results of these tests and their individualized diagnosis, the urologist will be able to define the stage of the disease. By analyzing the tumor tissue, received during surgery or biopsy, the pathologist determines the subtype of the tumor and whether or not it is aggressive. Together, the stage, subtype and aggressiveness of the tumor form the classification.
There are a number of poor prognostic factors that can help us predict the course of the disease: local or distant extension (metastases), high nuclear histologic grade (Furhman grade), onset of symptoms, anemia, high erythrocyte sedimentation rate (ESR), elevated alkaline phosphatase or elevated lactate dehydrogenase (LDH).
Renal tumor staging is used to estimate your individual prognosis. Based on this individualized prognosis, your doctor will discuss the best course of treatment for you. Kidney cancers are generally assigned a grade from 1 to 4.
To know if a kidney cyst is malignant, it is important to perform a series of studies and medical evaluations. The most common steps to determine the nature of a kidney cyst are: Renal ultrasound: ultrasound can show the shape and size of the cyst, as well as the presence of any suspicious features, such as irregular walls or inhomogeneous fluid. Computed tomography (CT): If the cyst has suspicious features on ultrasound, a CT scan may be done to obtain more detailed images. This helps to identify if there are solid masses within the cyst or changes in the cyst walls that suggest malignancy. Magnetic resonance imaging (MRI): is useful to better characterize the cyst and may provide additional information about its composition. This is particularly useful if there is doubt after the CT scan. Bosniak classification: The Bosniak classification system is used to categorize renal cysts based on their appearance on imaging and help determine the risk of malignancy. Biopsy: In some cases, if the cyst is suspected to be malignant or if imaging tests are inconclusive, a renal biopsy may be performed to obtain a sample of the tissue and examine it under the microscope. In general, benign kidney cysts do not cause symptoms. However, if a cyst becomes large, it may cause pain in the back or abdomen. If the cyst is malignant, there may be additional symptoms such as blood in the urine, unexplained weight loss or fatigue.
The most frequent areas to which kidney cancer can spread are the bones, liver, lungs, brain and distant lymph nodes.
In general, in patients with renal tumors under 4 cm that are treated surgically, cure rates of over 90% are achieved. If the mass is large and has spread outside the kidney, the prognosis is worse, especially if any of the following factors are present: anemia, high lactate dehydrogenase level, high blood calcium level, spread to two or more distant sites, or if the person's general condition is unfavorable.
Kidney cancer is curable in early stages. It is key that, once kidney cancer is treated, the patient is followed closely. In advanced stages of the tumor, surgery can help palliate symptoms and, in selected patients, can be combined with other treatments such as chemotherapy or immunotherapy to improve survival and quality of life.
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.